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Both human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) encode
a unique set of accessory proteins that enhance viral replication in the host. Two similar
accessory proteins, Vpx and Vpr, are encoded by HIV-2. In contrast, HIV-1 encodes Vpr but
not Vpx. Recent studies have indicated that Vpx counteracts a particular host restriction
factor, thereby facilitating reverse transcription in myeloid cells such as monocyte-derived
macrophages and monocyte-derived dendritic cells. This mechanism of counteraction is
similar to that of the accessory proteins Vif and Vpu which antagonize other host fac-
tors. In 2011, the protein SAMHD1 was identified as the restriction factor counteracted by
Vpx. Studies have since revealed that SAMHD1 degrades deoxynucleoside triphosphates
(dNTPs), which are components of viral genomic cDNA, in order to deprive viruses of
dNTPs. Although interactions between SAMHD1 and Vpx continue to be a major research
focus,Vpx has also been shown to have an apparent ability to enhance nuclear import of the
viral genome in T lymphocytes. This review summarizes the current knowledge regarding
SAMHD1-dependent and -independent functions of Vpx, and discusses possible reasons
why HIV-2 encodes both Vpx and Vpr, unlike HIV-1.
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INTRODUCTION
Human and simian immunodeficiency viruses (HIV/SIVs) carry
a unique set of accessory proteins, Vif, Vpx, Vpr, Vpu, and Nef,
which enhance viral replication in the host. Of these accessory
proteins, Vpx is unique to HIV-2-type viruses, defined in this
paper as the HIV/SIVs carrying both Vpr and Vpx, such as HIV-2,
SIVsmm (Sooty mangabey), and SIVmac (Rhesus monkey) (Fujita
et al., 2010). Vpr and Vpx are small proteins of approximately 100
amino acids and similar sequence (approximately 20–25% simi-
larity). Both Vpr and Vpx are predicted to have a similar structure
consisting of three major helices (Khamsri et al., 2006). In con-
trast, while HIV-1 carries Vpr, it does not carry Vpx. The answer to
the question why HIV-2 viruses encode these two similar proteins
while HIV-1 carries only one remains elusive, and must await the
determination of their functional details.
Extensive research over the past decade has revealed that
lentiviruses carry genes for accessory proteins that overcome host
antiviral factors. The first such accessory protein identified was Vif,
which inactivates APOBEC3 proteins, cellular cytidine deaminases
that restrict the replication of retroviruses by hypermutating viral
cDNA and/or inhibiting reverse transcription (Sheehy et al., 2002;
Goila-Gaur and Strebel, 2008; Kitamura et al., 2011). Vif reduces
the amount of APOBEC3 through proteasome-mediated degrada-
tion and other degradation-independent mechanisms. The second
major finding in this area was that the viral protein Vpu coun-
teracts host BST-2/tetherin, which normally blocks the release of
virions by directly tethering viral particles to the membranes of
infected cells (Neil et al., 2008; Van Damme et al., 2008; Arias et al.,
2011). The mechanism through which Vpu antagonizes the func-
tion of BST-2/tetherin may be proteasome/lysosome degradation
or relocalization from the cell surface.
Recently, it was reported that the viral accessory protein
Vpx inhibits the host restriction factor SAMHD1 in monocyte-
derived macrophages (MDMs) and monocyte-derived dendritic
cells (MDDCs) (Hrecka et al., 2011; Laguette et al., 2011), stim-
ulating interest in SAMHD1 and Vpx. In addition to inhibiting
SAMHD1 in MDMs and MDDCs, Vpx is also capable of enhanc-
ing viral replication in T lymphocytes (Guyader et al., 1989; Kappes
et al., 1991; Yu et al., 1991; Akari et al., 1992; Gibbs et al., 1994;
Kawamura et al., 1994; Tokunaga et al., 1997; Ueno et al., 2003;
Doi et al., 2011). In this review, we summarize current research
into SAMHD1-dependent and -independent functions of Vpx and
discuss the virological significance of this protein.
SAMHD1-DEPENDENT FUNCTIONS OF Vpx
Several studies have shown that while wild-type HIV-2-type
viruses grow well in MDMs, growth of these Vpx-deletion mutants
is completely suppressed, demonstrating that Vpx is essential for
viral replication in MDMs (Ueno et al., 2003; Fujita et al., 2008a).
It is known that Vpx is packaged in virions and functions in the
target cell. Independent work in our laboratory and that of another
group revealed that Vpx is critical for reverse transcription of
the viral RNA genome in MDMs (Fujita et al., 2008a; Srivastava
et al., 2008), correcting the long-held misconception that Vpx con-
tributes to nuclear import of the viral genome but does not play
a role in reverse transcription. Furthermore, Vpx was shown to
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induce proteasome-degradation of an unknown restriction fac-
tor to facilitate reverse transcription of the viral genome. It was
demonstrated that degradation of the unknown factor involves
formation of a Cul4-DDB1-DCAF1 E3 ligase complex (Sharova
et al., 2008; Bergamaschi et al., 2009; Kaushik et al., 2009). Con-
siderable effort was subsequently directed toward identification of
the unknown factor, and in 2011 SAMHD1 was identified as the
MDM host factor from co-immunoprecipitation studies of Vpx
expressed in THP-1 cells and in 293T cells (Hrecka et al., 2011;
Laguette et al., 2011). SAMHD1 has a tandem sterile alpha motif
(SAM) and HD domain with potential phosphohydrolase activ-
ity. The SAMHD1 protein was initially identified from MDDCs
as a homolog of mouse interferon-γ-induced protein (Li et al.,
2000), and is upregulated in response to viral infection (Prehaud
et al., 2005; Hartman et al., 2007; Zhao et al., 2008). Furthermore,
SAMHD1 is believed to be involved in regulating cellular intrinsic
antiviral responses (Rice et al., 2009).
The identification of SAMHD1 as a target of Vpx was not
sufficient to explain all the related phenomena, suggesting the
involvement of another factor (Hrecka et al., 2011; Planelles,2011).
However, based on reports indicating that SAMHD1 is a deoxynu-
cleoside triphosphate (dNTP) triphosphohydrolase (Goldstone
et al., 2011; Powell et al., 2011), it was hypothesized that SAMHD1
degrades dNTPs (which are small molecule components of viral
genomic cDNA) in order to deprive viruses of dNTPs by keep-
ing their concentration low. Lahouassa et al. (2012) recently
demonstrated the validity of this hypothesis (Figures 1 and 2).
Thus, the additional factor targeted by Vpx appears to be dNTPs.
Although dNTPs are utilized for reverse transcription in the
cytosol, they are small enough to freely diffuse through nuclear
pores in and out of the nucleus. Since SAMHD1 is a nuclear
protein (Rice et al., 2009), it is most likely that the concentra-
tion of dNTPs in the cytosol is controlled by SAMHD1 in the
nucleus. In fact, it was suggested that Vpx-mediated degradation
of SAMHD1 is initiated in the nucleus (Brandariz-Nuñez et al.,
2012; Figure 2).
In addition to being components of the viral genome, dNTPs
are components of the host genome; thus, proliferative CD4+
T cells do not express SAMHD1, and maintain the concentra-
tion of dNTPs at an optimal level for cell proliferation (2–4µM;
Lahouassa et al., 2012). In contrast, since MDMs do not proliferate,
they do not require high levels of dNTPs, and the low dNTP levels
(20–40 nM) resulting from SAMHD1-mediated degradation are
therefore not harmful to MDMs (Lahouassa et al., 2012). HIV-2-
type viruses carry Vpx for proteasome-mediated degradation of
SAMHD1 in order to facilitate replication in MDMs. In contrast,
HIV-1 does not require Vpx in order to replicate in MDMs (Fujita
et al., 2010) because its reverse transcriptase (RT) is capable of
catalyzing viral cDNA synthesis from very low levels of dNTPs
(Diamond et al., 2004; Lahouassa et al., 2012). The activity of
HIV-2 RT is probably lower [Michaelis constant (K m) of HIV-2
RT is higher] than that of HIV-1 RT, and therefore, to overcome
this disadvantage, HIV-2-type viruses may have evolved to carry
Vpx.
We previously mapped the functional region of Vpx involved
in viral replication in MDMs (Fujita et al., 2008a,b; Figure 3). It is
known that the region in major helix 3 containing amino acids Q76
FIGURE 1 | Function of SAMHD1 in MDMs. In reverse transcription, viral
cDNA is synthesized from dNTPs. The host restriction factor SAMHD1 is a
dNTP triphosphohydrolase that degrades dNTPs. Thus, in the presence of
SAMHD1, the concentration of dNTPs becomes low and reverse
transcription is inhibited.
and F80 interacts with DCAF1, a subunit of the Cullin4-based E3
ubiquitin ligase complex (Srivastava et al., 2008). This region could
overlap with a region that is critical for virion incorporation (Park
and Sodroski, 1995; Jin et al., 2001). Gramberg et al. (2010) sug-
gested that another region, which includes amino acids P9, N12,
E15, E16, and T17 in the N-terminal loop, binds to a restriction
factor; this region was later confirmed to be a SAMHD1-binding
region (Ahn et al., 2012).
We also identified several other functional regions in Vpx,
including a central region located between major helix 1 and major
helix 2, and a polyproline motif in a loop in the C-terminus (Fujita
et al., 2008a,b). We revealed that the C-terminal polyproline motif
is critical for stable expression of Vpx. Although the function of
the central region remains unknown, it has been confirmed that
this region is not involved in virion incorporation.
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FIGURE 2 | SAMHD1-dependent and -independent functions ofVpx. In the former function, Vpx degrades SAMHD1 to increase amounts of dNTPs (orange
circles), thus, reverse transcription proceeds (left). In the latter function, Vpx enhances reverse transcription and nuclear import by an unknown mechanism
(right).
FIGURE 3 | Mapping of the functional region ofVpx. In the upper
structure, the positions of predicted helices are shown in black (HIV-2
GL-AN clone; Khamsri et al., 2006). The region important for virion
packaging is shown. Middle diagram shows regions critical for
replication in MDMs: the SAMHD1-binding region (pink),
mechanistically unknown amino acid (yellow), mechanistically unknown
region (gray), DCAF1-binding region (light blue), and polyproline motif
(pale orange). Lower diagram shows regions involved in replication in
HSC-F cells: the mechanistically unknown region (gray), mechanistically
unknown and unique region (purple), and polyproline motif (pale
orange). The polyproline motif is critical for stable expression of Vpx. All
functionally important regions, except those for virion packaging,
SAMHD1-binding, and DCAF1-binding, are based on our report (Fujita
et al., 2008a,b).
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Following the identification of SAMHD1, several investigators
showed that although some cells such as undifferentiated THP-1
cells express SAMHD1, both the wild-type HIV-2-type virus and
its Vpx mutant infect these cells to an equivalent degree (Hrecka
et al., 2011; Planelles, 2011). There are several possible expla-
nations for the similar infectivity of wild-type and Vpx mutant
viruses: (1) These cells contain large amounts of dNTPs, and thus,
even in the presence of SAMHD1 there are sufficient quantities of
dNTPs for viral replication, and (2) SAMHD1 does not function in
these cells for some as yet unexplained reason. A plausible expla-
nation may be posttranslational modification (phosphorylation,
etc.) of the protein. Further study will be required to uncover the
molecular basis for this phenomenon.
Around the time SAMHD1 was identified, it was reported that
another host restriction factor, APOBEC3A, inhibits HIV-1 infec-
tion of MDMs, and that APOBEC3A is degraded by Vpx (Berger
et al., 2010, 2011). In addition, APOBEC3A reportedly decreases
the amount of viral cDNA synthesized during reverse transcrip-
tion. Presumably, degradation of SAMHD1 alone is not sufficient
to enable reverse transcription to proceed smoothly, and therefore
degradation of APOBEC3A is also required for viral replication in
MDMs, suggesting that Vpx functions to counteract the antiviral
effects of both APOBEC3A and SAMHD1. A comparative study
between APOBEC3A and SAMHD1 must be performed in order
to establish each protein’s contribution to restricting lentivirus
infection in myeloid cells.
SAMHD1-INDEPENDENT FUNCTIONS OF Vpx
Prior to the time that Vpx was found to act on reverse transcription
(Fujita et al., 2008a; Srivastava et al., 2008), it was thought that Vpx
is critical for nuclear import of the viral genome (Fletcher et al.,
1996; Pancio et al., 2000), based on the results of non-quantitative
polymerase chain reaction (PCR) studies. This notion was sup-
ported by the tendency of Vpx to localize in the nucleus when Vpx
is transduced to a cell solely (Pancio et al., 2000; Mahalingam et al.,
2001). It has been well established that Vpx is critical for reverse
transcription in MDMs, but this does not preclude participation
of Vpx in nuclear import in these cells. We previously identified
several Vpx mutants that are defective in both reverse transcription
and nuclear import (Fujita et al., 2010) in MDMs, which suggests
that Vpx also enhances nuclear import in these cells. We hypoth-
esize that this function of Vpx is SAMHD1-independent, since it
is plausible that there is no connection between the amount of
dNTPs and nuclear import. Further investigations are underway
in order to determine if this is indeed the case.
In T cells, such as peripheral blood lymphocytes (PBLs),periph-
eral blood mononuclear cells (PBMCs), and cultured simian
cell lines immortalized by Herpesvirus saimiri such as HSC-F
and M1.3S cells, HIV-2-type viruses grow well, but Vpx-deletion
mutants exhibit defective replication (Guyader et al., 1989; Kappes
et al., 1991; Yu et al., 1991; Akari et al., 1992; Gibbs et al., 1994;
Kawamura et al., 1994; Tokunaga et al., 1997; Ueno et al., 2003;
Doi et al., 2011). These results indicate that Vpx is also important
for viral replication in T cells. Dispensability of Vpx for the infec-
tion of T cells has been believed by some researchers (Bergamaschi
et al., 2009; Belshan et al., 2012), but this belief was probably based
on the results of infectious experiments using high-titer virus.
Our research showed that Vpx enhances nuclear import of the
viral genome in HSC-F cells, and that the smaller effect of Vpx on
reverse transcription was also observed (Ueno et al., 2003; Fujita
et al., 2008a; Figure 2). We mapped the region of Vpx involved
in viral replication in HSC-F cells (Fujita et al., 2008b; Figure 3)
and found that as is the case in MDMs, the central region and the
C-terminal polyproline motif are critical for replication. There is
also a unique functional region spanning from major helix 3 to
the C-terminal loop, but how this region influences infectivity is
unclear. The apparent SAMHD1- and DCAF-1-binding regions
are not necessary for viral replication in HSC-F cells, in contrast
to MDMs. Furthermore, in HSC-F and M1.3S cells, expression
of SAMHD1 was below the detectable level (Nomaguchi, M. and
Adachi, A., in preparation). Thus, in these cells, Vpx enhances
reverse transcription and nuclear import of the viral genome
through an unknown SAMHD1-independent mechanism. Not
only cultured cell lines, but also primary T cells are considered
to have SAMHD1-independent functions, since SAMHD1- and
DCAF-1-binding regions are dispensable for viral replication in
PBLs (Fujita, M. and Adachi, A., unpublished data).
It has been reported that Vpx is important for SIV infection in
monkeys, and the predominantly infected cells are the intraepithe-
lial T lymphocytes rather than myeloid cells such as macrophages
(Hirsch et al., 1998; Belshan et al., 2012). The Vpx in T cells
is considered to play a significant role in infection by HIV-2-
group viruses in vivo. Thus, we strongly suggest that SAMHD1-
independent functions of Vpx are also important, although almost
all the recent Vpx research has focused on SAMHD1-dependent
functions.
WHY DO HIV-2 VIRUSES HAVE TWO SIMILAR PROTEINS?
Lim et al. (2012) recently revealed that Vpr, a Vpx-related protein
found in HIV-1 and HIV-2-type viruses, is not involved in degra-
dation of SAMHD1. Instead, the Vpr carried by HIV-1 and HIV-2
arrests cells in the G2 phase of the cell cycle, a function not asso-
ciated with Vpx (Fletcher et al., 1996; Stivahtis et al., 1997; Fujita
et al., 2010; Table 1). This G2 arrest is known to be induced via for-
mation of a Cul4-DDB1-DCAF1 E3 ligase complex that includes
Vpr as an adaptor. Formation of the complex is followed by protea-
somal degradation of an unknown cellular target. This pathway is
similar to that involving Vpx, which also functions as an adaptor
for the Cul4-DDB1-DCAF1 E3 ligase complex to facilitate pro-
teasomal degradation of SAMHD1 (Ahn et al., 2012). Although
the virological significance of the Vpr-mediated G2 arrest has not
been determined, this function is likely to be important since it
Table 1 |The roles ofVpx andVpr in HIV-1 and HIV-2-type viruses.
HIV-1 HIV-2 type viruses
Reverse transcription at
low dNTP concentrations
(in MDMs)
Reverse transcriptase
(high activity)
Vpx
Induction of G2 arrest Vpr Vpr
Enhancement of nuclear
import
Vpr (?)a Vpx
aFurther study is required (see text).
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is broadly conserved among HIV/SIV. Since the activity of HIV-2
RT is lower than that of the enzyme found in HIV-1-type viruses,
HIV-2 may require SAMHD1 degradation in order to increase the
concentration of dNTPs, in addition to induction of G2 arrest.
Both of these functions, SAMHD1 degradation and G2 arrest,
are mediated via the Cul4-DDB1-DCAF1 E3 ligase complex.
SIVagm (African Green Monkey) is known to have only one Vpr,
which induces both the degradation of SAMHD1 (Lim et al., 2012)
and G2 arrest (Planelles et al., 1996; Stivahtis et al., 1997; Zhu et al.,
2001). Lim et al. proposed that in the evolution of HIV/SIVs,
neofunctionalization of Vpr to degrade SAMHD1 resulted in the
rapid evolution of the SAMHD1 protein, which induced the birth
of a similar protein, Vpx (subfunctionalization), to maximize its
SAMHD1-targeting capability. Here, we propose another reason
why HIV-2 viruses have similar proteins, Vpr and Vpx. It is known
that the region of HIV-1 Vpr spanning from major helix 3 to
the C-terminal loop (which includes a cluster of basic amino
acids) is critical for induction of G2 arrest (Di Marzio et al., 1995;
Selig et al., 1997; Jacquot et al., 2007). This region corresponds to
the mechanistically unknown and unique region of Vpx required
for replication in HSC-F cells (Figure 3; Khamsri et al., 2006;
Fujita et al., 2008b), but the corresponding region in Vpx does
not contain a cluster of basic amino acids in the C-terminal loop.
Induction of G2 arrest and enhancement of replication in T cells
may be incompatible functions for one protein. The presence of
both Vpr and Vpx may facilitate G2 arrest and enhancement of
HIV-2 replication in T cells, but a full explanation as to why HIV-2
has two proteins that are so similar will require further study.
CONCLUSION
Recent findings indicating that Vpx mediates the degradation
of SAMHD1 are intriguing, and reveal yet another example of
a virus with a means to counteract host defense mechanisms.
Table 1 summarizes the roles played by Vpx and Vpr in HIV-
1 and HIV-2. HIV-2/SIV Vpx negates the effect of the unique
host restriction factor SAMHD1 by inducing its degradation,
thereby enabling reverse transcription to occur under condi-
tions of low dNTP concentrations. In addition, Vpx enhances
reverse transcription and nuclear import of the viral genome in
an SAMHD1-independent manner. We are trying to isolate host
factor(s) which concern with SAMHD1-independent function.
Different regions of the Vpx protein are involved in mediat-
ing SAMHD1-dependent and -independent functions. A number
of HIV/SIV accessory proteins have multiple functions, includ-
ing HIV-1 Vpr (Fujita et al., 2010; Sharifi et al., 2012), Vpu
(Nomaguchi et al., 2008; Andrew and Strebel, 2010), and Nef (Fos-
ter and Garcia, 2008; Laguette et al., 2010). Importance of those
two functions of Vpx in the infected individuals should be revealed
in the future.
HIV-1 Vpr has a modest effect on replication in MDMs (Fujita
et al., 2010), and there have been reports that Vpr enhances nuclear
import of the viral genome in these cells (Tsurutani et al., 2000;
Agostini et al., 2002). It is possible that HIV-1 Vpr and HIV-2
Vpx function similarly with respect to nuclear import. However,
further study is required to elucidate how these proteins impact
nuclear import, since the role of HIV-1 Vpr was demonstrated
using non-quantitative PCR, and we could not reproduce this
result (Fujita et al., 2010).
Expression of Vpx in MDMs results in the degradation of
SAMHD1 and a subsequent increase in the concentration of
dNTPs, resulting in an increase in the infectivity of HIV-1. To date,
studies of Vpx/SAMHD1 have been mainly restricted to HIV-1,
even though Vpx is carried by HIV-2-type viruses. Through future
studies involving HIV-2-type viruses, we hope to provide a more
complete picture of the roles played by Vpx and Vpr.
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